Targeting the SDF-1/CXCR4 axis to attenuate pain in sickle cell disease: A preclinical evaluation of AMD3100 as a non-opioid therapeutic strategy Other Scholarly Work

Alishlash, Ammar, Malik, Simran, Lazrak, Ahmad et al. (2025). Targeting the SDF-1/CXCR4 axis to attenuate pain in sickle cell disease: A preclinical evaluation of AMD3100 as a non-opioid therapeutic strategy . BLOOD, 146 10.1182/blood-2025-4715

Open Access

cited authors

  • Alishlash, Ammar; Malik, Simran; Lazrak, Ahmad; Patel, Rakesh; DeBerry, Jennifer; Aggarwal, Saurabh

authors

publication date

  • November 3, 2025

published in

keywords

  • Hematology
  • Life Sciences & Biomedicine
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • ELSEVIER

volume

  • 146